|
|
||||||||
Neurology, Vol 50, Issue 6 1556-1562, Copyright © 1998 by American Academy of Neurology
ARTICLES |
S Tanaka, X Chen, Y Xia, DE Kang, N Matoh, M Sundsmo, RG Thomas, R Katzman, LJ Thal, JQ Trojanowski, T Saitoh, K Ueda and E Masliah
Department of Neurosciences, University of California at San Diego, La Jolla 92093-0624, USA.
OBJECTIVE: To examine the genetic association of CYP2D6 locus with Lewy body variant (LBV) and Parkinson's disease (PD). METHODS: Allelic association was studied in patients with pure AD, LBV, and PD by using the CYP2D microsatellite, the (dG-dT)n dinucleotide repeat (n=16 to 27) located between CYP2D8P and CYP2D7 genes, and the CYP2D6 B and D mutations. RESULTS: We found overrepresentation of the alleles longer than 21 repeat (the long-type alleles) in LBV (allele frequency, 0.313) (odds ratio=1.99, p=0.019 by chi2 test) and in PD (0.298) (odds ratio=1.86, p=0.037), but not in pure AD (0.196), compared with the age- matched control (0.186). Strong association was noted of the long-type alleles with the CYP2D6 B mutation (odds ratio=88.50, p < 0.001 by Fisher's exact test), but not with the D mutation or the deletion of CYP2D6 gene. CONCLUSIONS: The CYP2D locus is closely associated with LBV and PD. The CYP2D6 B mutation may be involved in pathogenesis of LBV and PD in a dominant-negative manner, or in the linkage disequilibrium of the CYP2D microsatellite to another pathogenic gene locus.
This article has been cited by other articles:
![]() |
V. Bogaerts, S. Engelborghs, S. Kumar-Singh, D. Goossens, B. Pickut, J. van der Zee, K. Sleegers, K. Peeters, J.-J. Martin, J. Del-Favero, et al. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder Brain, September 1, 2007; 130(9): 2277 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Miksys, C. Cheung, F. J. Gonzalez, and R. F. Tyndale HUMAN CYP2D6 AND MOUSE CYP2DS: ORGAN DISTRIBUTION IN A HUMANIZED MOUSE MODEL Drug Metab. Dispos., October 1, 2005; 33(10): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Huckvale, A M T Richardson, D M A Mann, and S M Pickering-Brown Debrisoquine hydroxylase gene polymorphism (CYP2D6*4) in dementia with Lewy bodies J. Neurol. Neurosurg. Psychiatry, January 1, 2003; 74(1): 135 - 136. [Full Text] [PDF] |
||||
![]() |
S.-I. Woo, L. A. Hansen, X. Yu, M. Mallory, and E. Masliah Alternative splicing patterns of CYP2D genes in human brain and neurodegenerative disorders Neurology, October 22, 1999; 53(7): 1570 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Licastro, I. L. Campbell, C. Kincaid, I. Veinbergs, E. Van Uden, E. Rockenstein, M. Mallory, J. R. Gilbert, and E. Masliah A Role for apoE in Regulating the Levels of {alpha}-1-Antichymotrypsin in the Aging Mouse Brain and in Alzheimer's Disease Am. J. Pathol., September 1, 1999; 155(3): 869 - 875. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |